Privacy·Terms·Disclaimer

Bibliographic data courtesy of the U.S. National Library of Medicine (NLM), sourced from PubMed/MEDLINE.

SciRadar is not affiliated with, endorsed by, or sponsored by NLM or NCBI. Abstracts remain © their respective publishers.

Proton Pump Inhibitors in the Era of Immunotherapy: A Risk Worth Taking? — SciRadar

Back to results

Journal of the National Comprehensive Cancer Network : JNCCN

Proton Pump Inhibitors in the Era of Immunotherapy: A Risk Worth Taking?

Sandra M Herrmann

Published: 202510.6004/jnccn.2025.7121

No abstract available for this study.